vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and FIRST HAWAIIAN, INC. (FHB). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $220.3M, roughly 1.2× FIRST HAWAIIAN, INC.). FIRST HAWAIIAN, INC. runs the higher net margin — 30.8% vs 1.4%, a 29.4% gap on every dollar of revenue. Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (5.3% CAGR vs 3.8%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
First Hawaiian, Inc. is a bank holding company headquartered in Honolulu, Hawaiʻi. Its principal subsidiary, First Hawaiian Bank, founded in 1858, is Hawaiʻi’s oldest and largest financial institution headquartered in Honolulu at the First Hawaiian Center. The bank has 57 branches throughout Hawaiʻi, three in Guam and one in Saipan. It offers banking services to consumer and commercial customers, including deposit products, lending services and wealth management, insurance, private banking an...
ACAD vs FHB — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $220.3M |
| Net Profit | $3.6M | $67.8M |
| Gross Margin | — | — |
| Operating Margin | -1.7% | — |
| Net Margin | 1.4% | 30.8% |
| Revenue YoY | 9.7% | — |
| Net Profit YoY | — | 14.4% |
| EPS (diluted) | $0.02 | $0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | $220.3M | ||
| Q4 25 | $284.0M | $225.9M | ||
| Q3 25 | $278.6M | $226.4M | ||
| Q2 25 | $264.6M | $217.5M | ||
| Q1 25 | $244.3M | $211.0M | ||
| Q4 24 | $259.6M | $188.1M | ||
| Q3 24 | $250.4M | $210.0M | ||
| Q2 24 | $242.0M | $204.6M |
| Q1 26 | $3.6M | $67.8M | ||
| Q4 25 | $273.6M | $69.9M | ||
| Q3 25 | $71.8M | $73.8M | ||
| Q2 25 | $26.7M | $73.2M | ||
| Q1 25 | $19.0M | $59.2M | ||
| Q4 24 | $143.7M | $52.5M | ||
| Q3 24 | $32.8M | $61.5M | ||
| Q2 24 | $33.4M | $61.9M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | -1.7% | — | ||
| Q4 25 | 6.1% | 41.2% | ||
| Q3 25 | 12.8% | 42.5% | ||
| Q2 25 | 12.2% | 40.5% | ||
| Q1 25 | 7.9% | 36.5% | ||
| Q4 24 | 59.1% | 34.4% | ||
| Q3 24 | 12.6% | 36.4% | ||
| Q2 24 | 12.6% | 39.5% |
| Q1 26 | 1.4% | 30.8% | ||
| Q4 25 | 96.3% | 31.0% | ||
| Q3 25 | 25.8% | 32.6% | ||
| Q2 25 | 10.1% | 33.7% | ||
| Q1 25 | 7.8% | 28.1% | ||
| Q4 24 | 55.4% | 27.9% | ||
| Q3 24 | 13.1% | 29.3% | ||
| Q2 24 | 13.8% | 30.3% |
| Q1 26 | $0.02 | $0.55 | ||
| Q4 25 | $1.61 | $0.56 | ||
| Q3 25 | $0.42 | $0.59 | ||
| Q2 25 | $0.16 | $0.58 | ||
| Q1 25 | $0.11 | $0.47 | ||
| Q4 24 | $0.86 | $0.41 | ||
| Q3 24 | $0.20 | $0.48 | ||
| Q2 24 | $0.20 | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | $0 |
| Stockholders' EquityBook value | — | $2.8B |
| Total Assets | $1.6B | $24.3B |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | — | ||
| Q2 25 | $253.6M | — | ||
| Q1 25 | $217.7M | — | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $155.1M | — | ||
| Q2 24 | $177.1M | — |
| Q1 26 | — | $0 | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $2.8B | ||
| Q4 25 | $1.2B | $2.8B | ||
| Q3 25 | $917.3M | $2.7B | ||
| Q2 25 | $822.4M | $2.7B | ||
| Q1 25 | $765.2M | $2.6B | ||
| Q4 24 | $732.8M | $2.6B | ||
| Q3 24 | $577.2M | $2.6B | ||
| Q2 24 | $516.7M | $2.6B |
| Q1 26 | $1.6B | $24.3B | ||
| Q4 25 | $1.6B | $24.0B | ||
| Q3 25 | $1.3B | $24.1B | ||
| Q2 25 | $1.2B | $23.8B | ||
| Q1 25 | $1.1B | $23.7B | ||
| Q4 24 | $1.2B | $23.8B | ||
| Q3 24 | $976.9M | $23.8B | ||
| Q2 24 | $914.1M | $24.0B |
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
Segment breakdown not available.
FHB
| Net Interest Income | $167.5M | 76% |
| Noninterest Income | $52.8M | 24% |
